Investors dump Juno on clinical hold

Juno Therapeutics Inc. (NASDAQ:JUNO) fell 32% on Friday, as investors sold on late Thursday's news that FDA placed a clinical hold on

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE